Filing Details
- Accession Number:
- 0001127602-12-012911
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-04-03 13:00:00
- Reporting Period:
- 2012-04-02
- Filing Date:
- 2012-04-03
- Accepted Time:
- 2012-04-03 16:11:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
912183 | Cubist Pharmaceuticals Inc | CBST | Pharmaceutical Preparations (2834) | 223192085 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1320122 | Martin Rosenberg | 65 Hayden Avenue Lexington MA 02421 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-04-02 | 10,000 | $0.00 | 14,658 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-04-02 | 10,000 | $42.76 | 4,658 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | Disposition | 2012-04-02 | 10,000 | $0.00 | 10,000 | $21.88 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
2,500 | 2008-06-07 | 2017-06-07 | No | 4 | M | Direct |
Footnotes
- Option vests 100% on one-year anniversary of grant.
- Sold pursuant to a Rule 10(b)5-1 Plan
- This transaction was executed in multiple trades at prices ranging from $42.52 to $43.1150. The price reported in the table reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.